You are trying to access subscriber-only content.

If you are a subscriber, log in here.

If you are not a subscriber, or are only subscribed to the print edition, click here to subscribe now. Digital subscribers have unlimited access to our magazine articles and more!

Scientists at UCLA have developed an innovative method to enhance the effectiveness of immune cells for potential use in “off-the-shelf” cell therapy, particularly for treating challenging cancers. “Off-the-shelf” cell therapy, also known as allogenic therapy, uses immune cells derived from healthy donors instead of patients. Traditional cell therapies, like chimeric antigen receptor (CAR) T cell […]